Open access · Peer reviewed · No APCs
Review ArticleIndian Journal of Pharmacy PracticeVol. 7 | Issue 3 | 2014 | pp. 19–22Open access
Current Status of Adverse Drug Reactions Monitoring Centres under Pharmacovigilance Programme of India
- 1*,
- 1,
- 2
- 1 Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India, Sector 23, Rajnagar, Ghaziabad 201002 (U.P), India.
- 2 Faculty of Pharmacy, Jamia Hamdard, Deemed University, Hamdard Nagar, New Delhi 110 062, India.
Published in Indian Journal of Pharmacy Practice
Correspondence: V Kalaiselvan
Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India, Sector 23, Rajnagar, Ghaziabad 201002 (U.P), India.
Email: vivekarts@rediffmail.com
Copyright: © 2014 Manuscript Technomedia. This is an open access article.
- Published:
- Jul 15, 2014
- Received:
- Apr 3, 2014
- Accepted:
- Sep 4, 2014
- DOI:
- 10.5530/ijopp.7.3.5
How to cite
Kalaiselvan, V., Thota, P., & Singh, A. (2014). Current Status of Adverse Drug Reactions Monitoring Centres under Pharmacovigilance Programme of India. Indian Journal of Pharmacy Practice, 7(3), 19–22. https://doi.org/10.5530/ijopp.7.3.5
Abstract
There are one hundred and fifty Adverse Drug Reactions Monitoring Centres (AMCs) across the country are functioning and reporting’s Adverse Drug Reactions to National Coordination centre (NCC), Pharmacovigilance Programme of India (PvPI) at Indian Pharmacopoeia Commission (IPC), Ghaziabad. The AMCs are established to collate data on Pharmacovigilance and forward to NCC via online software (VigiFlow). The present AMCs are Medical Council of India (MCI) approved teaching hospitals and corporate hospitals. NCC is working with AMCs to coordinate with Pharmacy institutions to enhance ADRs reporting.
Keywords
Subject
Article metadata
| Title | Current Status of Adverse Drug Reactions Monitoring Centres under Pharmacovigilance Programme of India |
|---|---|
| Authors | V Kalaiselvan; Prasad Thota; Abishank Singh |
| Affiliations | Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India, Sector 23, Rajnagar, Ghaziabad 201002 (U.P), India.; Faculty of Pharmacy, Jamia Hamdard, Deemed University, Hamdard Nagar, New Delhi 110 062, India. |
| Corresponding author | vivekarts@rediffmail.com |
| Journal | Indian Journal of Pharmacy Practice |
| Volume / Issue | Vol. 7, Issue 3 (2014) |
Also in this issue
- Editorialpp. 1–1
- Combating Increasing Chronic Non Communicable Diseases: The Need, Progress and Way Forward for Health Promoting Schools in South Africapp. 2–9
- Need for Problem-Based Learning in Clinical Pharmacy Education in Indiapp. 10–13
- Clinical Pharmacist in Nuclear Medicine: A New Role in Ascendancypp. 14–18
- A Global Comparison Between Brand-Name and Generic Drugspp. 23–28
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026